Gyre Therapeutics, Inc. - Current Ratio

The Current Ratio as of September 2026 (TTM) for Gyre Therapeutics, Inc. (GYRE) is 4.26

According to Gyre Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.26. This represents a change of -17.65% compared to the average of 5.17 of the last 4 quarters.

Gyre Therapeutics, Inc. (GYRE) Historical Current Ratio (quarterly & annually)

How has GYRE Current Ratio performed in the past?

The mean historical Current Ratio of Gyre Therapeutics, Inc. over the last ten years is 5.98. The current 4.26 Current Ratio has changed 7.02% with respect to the historical average. Over the past ten years (40 quarters), GYRE's Current Ratio was at its highest in in the June 2018 quarter at 56.98. The Current Ratio was at its lowest in in the September 2016 quarter at 1.59.

Gyre Therapeutics, Inc. (GYRE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Gyre Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gyre Therapeutics, Inc. (GYRE) Average Current Ratio

How has GYRE Current Ratio performed in the past?

The current Current Ratio of Gyre Therapeutics, Inc. (GYRE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Gyre Therapeutics, Inc. (GYRE) Current Ratio vs. Peers

How is GYRE’s Current Ratio compared to its peers?

Gyre Therapeutics, Inc.’s Current Ratio is less than Anavex Life Sciences Corp. (15.62), less than Erasca, Inc. (8.29), less than CytomX Therapeutics, Inc. (9.36), less than MBX Biosciences, Inc. Common Stock (18.08), less than MoonLake Immunotherapeutics (12.56), less than Astria Therapeutics, Inc. (10.78), less than Keros Therapeutics, Inc. (21.96), greater than MeiraGTx Holdings plc (3.76), less than Iovance Biotherapeutics, Inc. (4.35), less than ArriVent BioPharma, Inc. (14.16),

Build a custom stock screener for Gyre Therapeutics, Inc. (GYRE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gyre Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gyre Therapeutics, Inc. (GYRE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gyre Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.